Hind Rafei
hindrafei.bsky.social
Hind Rafei
@hindrafei.bsky.social
Physician-scientist at MD Anderson Cancer Center investigating cellular immunotherapy for solid cancers with a focus on the solid TME. Opinions are my own.
Reposted by Hind Rafei
Congratulations to the 2025 Sabin Family Fellowship recipients, 10 early career researchers recognized for their bold, high-impact cancer research.

Thank you to the Sabin Family Fellowship for supporting the next generation of innovators. http://spr.ly/633254IbgR #EndCancer
MD Anderson announces 10th cohort of Andrew Sabin Family Fellows
The University of Texas MD Anderson Cancer Center today announced its 10th cohort of Andrew Sabin Family Fellows, comprised of 10 early career cancer researchers. Created to provide a dedicated source of funding for emerging clinician and scientist leaders, the Sabin Family Fellowship supports groundbreaking research that fuels MD Anderson’s mission to end cancer.
spr.ly
July 11, 2025 at 1:23 PM
Reposted by Hind Rafei
Don't miss this killer episode!

Dr. Rizwan Romee talks about #NaturalKiller cells and how they can be engineered to target cancers.

Check it out: bit.ly/3I19hq6
June 18, 2025 at 6:08 PM
Reposted by Hind Rafei
Nature research paper: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

https://go.nature.com/4mNx4tJ
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells - Nature
The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeric antigen receptors.
go.nature.com
June 9, 2025 at 1:50 PM
I’m thrilled to share our work out now in Nature identifying CREM as a central intracellular checkpoin in #CARNK cells.

📄Link: nature.com/articles/s41...

Our story👇🏼
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells - Nature
The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeri...
nature.com
June 5, 2025 at 3:03 AM